WORCESTER, Mass.--(BUSINESS WIRE)--RXi Pharmaceuticals Corporation (Nasdaq: RXII), a recognized leader in RNAi-based therapeutic discovery and development, today announced that the Company’s President and Chief Executive Officer, Noah D. Beerman, will present a corporate overview at the 2011 BIO CEO & Investor Conference on Monday, February 14, 2011 at 10:00 a.m. ET.
